Fig. 2From: Balance Right in Multiple Sclerosis (BRiMS): a feasibility randomised controlled trial of a falls prevention programmeBRiMS programme delivery plan. SAE: serious adverse reactions (as classified by the study principle investigator/ chief investigator (see study protocol for details) [9]. Only a sub-group of participants were invited to participate in the qualitative interview.** One participant did not complete baseline data for the EQ5D-5L potential primary outcomeBack to article page